U Schmidt

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Genetic engineering of brewing yeast to reduce the content of ethanol in beer

Elke Nevoigt, Rita Pilger, Edeltraud Mast-Gerlach et al. · FEMS Yeast Research · 2002 · 69 citations

Agriculture, Bioengineering, Biotechnology +17

Efficacy of the Hawthorn (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class II

U Schmidt, Ulrike Kühn, Michał Ploch et al. · Phytomedicine · 1994 · 69 citations

Medicine, Cardiology, Internal Medicine +6

Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells

Dorothea Siegel‐Axel, Susanne Ullrich, Norbert Stefan et al. · Diabetologia · 2014 · 59 citations

Life Sciences, Biochemistry, Cell Biology +7